Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21(Waf1/Cip1), and Caspase-9/-3 activation

The leucine-rich repeat containing 8A (LRRC8A) protein is an essential component of the volume-sensitive organic anion channel (VSOAC), and using pharmacological anion channel inhibitors (NS3728, DIDS) and LRRC8A siRNA we have investigated its role in development of Cisplatin resistance in human ova...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Physiol Cell Physiol
Main Authors: Sørensen, Belinda Halling, Nielsen, Dorthe, Thorsteinsdottir, Unnur Arna, Hoffmann, Else Kay, Lambert, Ian Henry
Formato: Artigo
Idioma:Inglês
Publicado em: American Physiological Society 2016
Assuntos:
Call for Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4935196/
https://ncbi.nlm.nih.gov/pubmed/26984736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpcell.00256.2015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados